Policy for IDG Consortium Interaction with Other Entities (Consortia/Institutes /Associations/Biotech/Pharma)
Published in 2018
Description:IDG members are encouraged to foster collaborations and interactions with individual laboratories/researchers, consortia, associations, pharma, and biotech, as well as other outside entities. The guidelines outlined here are to enhance these interactions for the benefit of sharing IDG outcomes.
Collections/recommendations derived from this policy:
- This policy implements the collection IDG Project.
How to cite this record FAIRsharing.org: Policy for IDG Consortium Interaction with Other Entities (Consortia/Institutes /Associations/Biotech/Pharma); DOI: https://doi.org/10.25504/FAIRsharing.7KZpOx; Last edited: Dec. 19, 2019, 11:07 a.m.; Last accessed: Oct 26 2021 5:01 p.m.
Edits to 'https://fairsharing.org/FAIRsharing.7KZpOx' by 'The FAIRsharing Team' at 11:31, 04 Nov 2019 (approved): 'taxonomies' has been modified: Before: After: Not applicable Added: Not applicable Removed: 'onto_disciplines' has been modified: Before: After: Health Science Knowledge and Information Systems Medical Informatics Public Health Added: Health Science Knowledge and Information Systems Medical Informatics Public Health Removed: 'onto_domains' has been modified: Before: After: drug metabolic process Added: drug metabolic process Removed:
NIH (Government body)
Illuminating the Druggable Genome (IDG) consortium (Consortium)
TOP Level Data Transparency: Not available
TOP qualifying comments: Not available
No Databases Listed
No Standards Listed
Conditions of Use
|Contact||IDG Resource Outreach and Dissemination Center|